Searched for
AUROBINDO HEALTHCARE
Capitalmind Flexi Cap Fund adds Nestle India and 10 others, exits SBI and 14 others in MayCapitalmind Flexi Cap Fund made significant portfolio adjustments in May. The fund welcomed Nestle India and eleven new stocks. It also div...- Quant Mid Cap Fund adds Adani Energy and 4 others, exits Paytm and 3 more stocks in MayQuant Mid Cap Fund, managed by Sandeep Tandon, has strategically adjusted its portfolio in May. The fund added Adani Energy and four other ...
- Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...
- Bernstein initiates coverage on 6 pharma stocks, cites 3 major tailwinds for healthcare sectorBernstein has initiated coverage on six Indian pharma stocks, with Zydus Lifesciences as its top choice. The brokerage sees strong future g...
- Quant Mid Cap Fund exits Lenskart Solutions and 2 other stocks, adds SAIL in AprilQuant Mid Cap Fund exited Lenskart Solutions, NMDC and SBI Cards in April, while adding Steel Authority of India to its portfolio, the fund...
- Pharma Q4 outlook mixed: Hospitals steady, generics face revlimid dragIndian pharma and healthcare firms face a mixed March quarter. While hospitals anticipate steady growth, generic drugmakers grapple with lo...
- Aurobindo Pharma shares rise 2% after subsidiary CuraTeQ gets UK nod for DyrupegAurobindo Pharma shares: In the March quarter, Aurobindo Pharma posted a consolidated revenue of ₹8,382.1 crore, marking an 11% increase co...
- Healthcare stocks rally over 2% as CLSA upgrades Dr Lal Pathlabs and Aurobindo; DRL drops on downgradeHealthcare stocks see mixed performance as Dr Lal Pathlabs and Aurobindo Pharma rise over 2% after CLSA upgrades their ratings to 'outperfo...
- Aurobindo, Cipla, Viatris in licensing pact with MPP to make ViiV's HIV preventive therapyThrough the MPP-ViiV Healthcare agreement, the three generic manufacturers will be able to develop, manufacture, and supply generic version...
- Aurobindo Pharma taps PEs for stake sale in injectable businessAs part of expanding the injectable business, Aurobindo is setting up a dedicated injectable facility in Vizag for the EU and other global ...
- Aurobindo Pharma gets USFDA nod for generic antidepressant tabletsThe company has received the final approval from the US Food and Drug Administration (USFDA) to manufacture and market Fluoxetine tablets i...
- Aurobindo Pharma arm enters pact to form JV in China with Luoxin"The percentage of shareholding in the joint venture company will be 30 per cent and 70 per cent between Helix and Luoxin," Aurobindo Pharm...
- Aurobindo Pharma gets USFDA nod for anti-HIV drugAurobindo Pharma has received tentative approval from the USFDA for dolutegravir, lamivudine and tenofovir disoproxil fumarate tablets, use...
- Aurobindo Pharma gets USFDA nod for HIV drug"The company has received final approval from the USFDA to manufacture abacavir sulfate and lamivudine tablets, 600 mg/ 300 mg."
- Aurobindo Pharma may buy Portugal's Generis, deal likely to be valued at $200 millionAurobindo's latest bid comes on the heels of last month’s shot at Israeli drug maker Teva's UK product portfolio, where it was outbid by ri...
- Aurobindo Pharma, Cadila recall drugs from US marketPantoprazole Sodium delayed-release tablets are used for treatment of erosive inflammation of the esophagus due to acid reflux.
- Aurobindo Pharma gets USFDA nod for Esomol Hydrochloride InjectionAurobindo Pharma Limited said it has received final approvals from the US Food and Drug Administration to manufacture and market Esmolol Hy...
- IT, Pharma under pressure; Infosys, TCS, Sun Pharma take a hitStocks in IT and pharma sector took a beating for a 2nd consecutive session on Monday, weighed down by the rupee which hit its strongest in...
- Aurobindo Pharma gets USFDA approval for HIV drugAurobindo Pharma said it has received US health regulator's final approval to market Abacavir Tablets, used in the treatment of HIV in the ...
- Cipla and Ranbaxy are showing strength: EdelweissJitendra Mehta, technical analyst, Edelweiss, in a chat with ET Now talks about Strides Arcolab or an Aurobindo Pharma.
Load More
